Lupin to foray into the digital healthcare space
    Home » Digitisation » Lupin to foray into the digital healthcare space
Digitisation

Lupin to foray into the digital healthcare space

The company recently incorporated a new entity in the name of Lupin Digital Health Limited

  • By IPP Bureau | June 03, 2021

The Board of Directors of Lupin Ltd has approved the Company's entry into the digital healthcare space with a focus to provide a digital therapeutics platform for doctors and patients in India.

The company recently incorporated a new entity in the name of Lupin Digital Health Limited, as a wholly owned subsidiary, which will undertake this.

Upcoming E-conference

Other Related stories

Lonza launches AI-enabled Route Scouting Service to accelerate small molecule development
Parexel and Palantir to accelerate clinical data delivery and power clinical outcomes for patients
Dr. Reddy’s launches integrated care plan to manage irritable bowel syndrome
View More

Interviews

Capex comm
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Our focus
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
We have co
We have consistently expanded our business in India: Vinod Paremal, President & MD, Evonik, India Region
View More

Appointments

Gland Pharma appoints Satnam Singh Loomba as COO
Gland Pharma appoints Satnam Singh Loomba as COO
Merck India appoints Dhananjay Singh as MD Merck Life Science in India
Merck India appoints Dhananjay Singh as MD Merck Life Science in India
Lupin appoints Dr. Ranjana Pathak as Chief Quality Officer
Lupin appoints Dr. Ranjana Pathak as Chief Quality Officer
View More

Startup

Pfizer joins hands with NIPER (Ahmedabad) to support Healthcare Innovation in India
Pfizer joins hands with NIPER (Ahmedabad) to support Healthcare Innovation in India
DPIIT recognises 1, 17,254 startups as on Dec 2023
DPIIT recognises 1, 17,254 startups as on Dec 2023
SigTuple’s AI100 with Shonit receives USFDA 510(k) clearance
SigTuple’s AI100 with Shonit receives USFDA 510(k) clearance
View More

Digitization

Lonza launches AI-enabled Route Scouting Service to accelerate small molecule development
Lonza launches AI-enabled Route Scouting Service to accelerate small molecule development
Parexel and Palantir to accelerate clinical data delivery and power clinical outcomes for patients
Parexel and Palantir to accelerate clinical data delivery and power clinical outcomes for patients
Dr. Reddy’s launches integrated care plan to manage irritable bowel syndrome
Dr. Reddy’s launches integrated care plan to manage irritable bowel syndrome
View More

Latest Stories

Philips Respironics agrees to pay $1.1 billion settlement after CPAP machine recall

Novartis and Medicines for Malaria Venture announce positive efficacy and safety data

Lilly posts Q1 2024 revenue up 26% at US$ 8.77 billion

Granules India announced ANDA Approval for Colchicine Capsules

Lonza launches AI-enabled Route Scouting Service to accelerate small molecule development

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Opinion
Defending Public Health: Strategies to safeguard pharmaceutical quality: Raheel Shah, Business Development Director, BDR Pharmaceuticals
Defending Public Health: Strategies to safeguard pharmaceutical quality: Raheel Shah, Business Development Director, BDR Pharmaceuticals
Advanced Treatments for Brain Tumors: Secure Procedures Available
Advanced Treatments for Brain Tumors: Secure Procedures Available

Interviews
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Dr. R. Ananthanarayanan CEO, Sajjan India
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Dr. Aman Desai Promoter and Whole Time Director, Aether Industries
We have consistently expanded our business in India: Vinod Paremal, President & MD, Evonik, India Region
We have consistently expanded our business in India: Vinod Paremal, President & MD, Evonik, India Region
Vinod Paremal President & MD, Evonik, India Region

Packaging
Sulzer launches new biodegradable polymer
Sulzer launches new biodegradable polymer
Solvay launches new PVDC coating solution for more sustainable pharma blister films
Solvay launches new PVDC coating solution for more sustainable pharma blister films
PCI Pharma plans Biologics assembly facility in the Midwest
PCI Pharma plans Biologics assembly facility in the Midwest